Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE41.1300
- TODAY'S CHANGE (%)-0.3700 (-0.8916%)
- Bid / Lots41.1200/ 13
- Ask / Lots41.1300/ 14
- Open / Previous Close41.2700 / 41.5000
- Day Range
- 52 Week Range
- Volume599,774
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 8398 | 41.335 |
| 09:34 ET | 100 | 41.23 |
| 09:36 ET | 200 | 41.325 |
| 09:38 ET | 3826 | 41.27 |
| 09:39 ET | 1100 | 41.2 |
| 09:41 ET | 1500 | 41.32 |
| 09:43 ET | 100 | 41.32 |
| 09:45 ET | 600 | 41.3 |
| 09:48 ET | 1000 | 41.23 |
| 09:50 ET | 498 | 41.21 |
| 09:52 ET | 100 | 41.24 |
| 09:54 ET | 400 | 41.26 |
| 09:56 ET | 927 | 41.22 |
| 09:57 ET | 1650 | 41.145 |
| 09:59 ET | 915 | 41.03 |
| 10:01 ET | 1532 | 40.985 |
| 10:03 ET | 1700 | 41.065 |
| 10:06 ET | 1109 | 41.01 |
| 10:08 ET | 2924 | 40.99 |
| 10:10 ET | 3139 | 40.882 |
| 10:12 ET | 1256 | 40.96 |
| 10:14 ET | 400 | 40.98 |
| 10:15 ET | 700 | 40.945 |
| 10:17 ET | 1862 | 40.96 |
| 10:19 ET | 900 | 40.95 |
| 10:21 ET | 1200 | 40.985 |
| 10:24 ET | 800 | 41.055 |
| 10:26 ET | 600 | 41.1 |
| 10:28 ET | 1224 | 41.04 |
| 10:30 ET | 575 | 41.02 |
| 10:32 ET | 1100 | 40.96 |
| 10:33 ET | 800 | 40.94 |
| 10:35 ET | 1495 | 40.85 |
| 10:37 ET | 836 | 40.77 |
| 10:39 ET | 757 | 40.78 |
| 10:42 ET | 2745 | 40.8 |
| 10:44 ET | 400 | 40.76 |
| 10:46 ET | 1175 | 40.82 |
| 10:50 ET | 200 | 40.94 |
| 10:51 ET | 7400 | 41 |
| 10:53 ET | 5904 | 40.955 |
| 10:55 ET | 200 | 40.95 |
| 10:57 ET | 1192 | 40.95 |
| 11:02 ET | 900 | 41.02 |
| 11:04 ET | 100 | 41.06 |
| 11:06 ET | 100 | 41.06 |
| 11:08 ET | 900 | 41.08 |
| 11:09 ET | 1374 | 41.1 |
| 11:11 ET | 779 | 41.06 |
| 11:13 ET | 902 | 41.03 |
| 11:15 ET | 300 | 41.02 |
| 11:18 ET | 100 | 41.045 |
| 11:20 ET | 300 | 41.045 |
| 11:22 ET | 797 | 41.0305 |
| 11:24 ET | 7065 | 40.99 |
| 11:26 ET | 100 | 40.99 |
| 11:27 ET | 300 | 40.99 |
| 11:29 ET | 13201 | 41.08 |
| 11:31 ET | 1790 | 41.14 |
| 11:33 ET | 400 | 41.2 |
| 11:36 ET | 500 | 41.17 |
| 11:38 ET | 600 | 41.1881 |
| 11:40 ET | 2169 | 41.16 |
| 11:42 ET | 300 | 41.11 |
| 11:44 ET | 500 | 41.08 |
| 11:45 ET | 815 | 41.1 |
| 11:47 ET | 700 | 41.09 |
| 11:49 ET | 1000 | 41.08 |
| 11:51 ET | 3692 | 41.08 |
| 11:54 ET | 100 | 41.0825 |
| 11:56 ET | 1460 | 41.215 |
| 11:58 ET | 400 | 41.24 |
| 12:00 ET | 3812 | 41.28 |
| 12:02 ET | 2040 | 41.25 |
| 12:05 ET | 500 | 41.29 |
| 12:07 ET | 1170 | 41.32 |
| 12:09 ET | 400 | 41.37 |
| 12:12 ET | 100 | 41.39 |
| 12:14 ET | 2062 | 41.44 |
| 12:16 ET | 487 | 41.44 |
| 12:18 ET | 1342 | 41.42 |
| 12:20 ET | 1924 | 41.36 |
| 12:21 ET | 400 | 41.355 |
| 12:23 ET | 320 | 41.32 |
| 12:25 ET | 100 | 41.315 |
| 12:27 ET | 300 | 41.3 |
| 12:30 ET | 700 | 41.28 |
| 12:32 ET | 1500 | 41.29 |
| 12:34 ET | 557 | 41.29 |
| 12:36 ET | 1500 | 41.33 |
| 12:38 ET | 901 | 41.35 |
| 12:39 ET | 700 | 41.36 |
| 12:41 ET | 200 | 41.37 |
| 12:43 ET | 700 | 41.425 |
| 12:45 ET | 935 | 41.43 |
| 12:48 ET | 600 | 41.47 |
| 12:50 ET | 1001 | 41.46 |
| 12:52 ET | 500 | 41.47 |
| 12:54 ET | 903 | 41.48 |
| 12:56 ET | 4260 | 41.4 |
| 12:57 ET | 300 | 41.36 |
| 12:59 ET | 200 | 41.36 |
| 01:01 ET | 300 | 41.34 |
| 01:03 ET | 100 | 41.365 |
| 01:06 ET | 1743 | 41.44 |
| 01:08 ET | 200 | 41.44 |
| 01:10 ET | 100 | 41.44 |
| 01:12 ET | 100 | 41.42 |
| 01:14 ET | 315 | 41.42 |
| 01:15 ET | 1100 | 41.4 |
| 01:17 ET | 1000 | 41.4 |
| 01:19 ET | 20115 | 41.4417 |
| 01:21 ET | 42300 | 41.43 |
| 01:24 ET | 200 | 41.41 |
| 01:26 ET | 1100 | 41.34 |
| 01:28 ET | 627 | 41.365 |
| 01:30 ET | 531 | 41.34 |
| 01:32 ET | 400 | 41.32 |
| 01:33 ET | 695 | 41.285 |
| 01:35 ET | 1400 | 41.33 |
| 01:37 ET | 343 | 41.3393 |
| 01:39 ET | 319 | 41.31 |
| 01:42 ET | 1414 | 41.33 |
| 01:44 ET | 620 | 41.31 |
| 01:46 ET | 200 | 41.31 |
| 01:48 ET | 300 | 41.32 |
| 01:50 ET | 200 | 41.31 |
| 01:51 ET | 1500 | 41.32 |
| 01:53 ET | 500 | 41.34 |
| 01:55 ET | 1864 | 41.365 |
| 02:00 ET | 100 | 41.375 |
| 02:02 ET | 1900 | 41.34 |
| 02:04 ET | 1450 | 41.305 |
| 02:06 ET | 1700 | 41.29 |
| 02:08 ET | 1511 | 41.275 |
| 02:09 ET | 700 | 41.24 |
| 02:11 ET | 950 | 41.3 |
| 02:13 ET | 200 | 41.305 |
| 02:15 ET | 400 | 41.3 |
| 02:18 ET | 1500 | 41.29 |
| 02:20 ET | 1770 | 41.32 |
| 02:22 ET | 100 | 41.33 |
| 02:24 ET | 100 | 41.34 |
| 02:26 ET | 2000 | 41.375 |
| 02:27 ET | 2155 | 41.33 |
| 02:29 ET | 200 | 41.32 |
| 02:31 ET | 200 | 41.32 |
| 02:33 ET | 1055 | 41.34 |
| 02:36 ET | 300 | 41.34 |
| 02:38 ET | 3834 | 41.37 |
| 02:40 ET | 100 | 41.35 |
| 02:42 ET | 1050 | 41.34 |
| 02:44 ET | 888 | 41.36 |
| 02:45 ET | 1413 | 41.335 |
| 02:47 ET | 1347 | 41.31 |
| 02:49 ET | 400 | 41.3 |
| 02:51 ET | 500 | 41.31 |
| 02:54 ET | 616 | 41.32 |
| 02:56 ET | 2479 | 41.34 |
| 02:58 ET | 1379 | 41.33 |
| 03:00 ET | 540 | 41.34 |
| 03:02 ET | 3234 | 41.365 |
| 03:03 ET | 875 | 41.385 |
| 03:05 ET | 706 | 41.375 |
| 03:07 ET | 2558 | 41.36 |
| 03:09 ET | 230 | 41.3599 |
| 03:12 ET | 2623 | 41.36 |
| 03:14 ET | 400 | 41.365 |
| 03:16 ET | 460 | 41.365 |
| 03:18 ET | 2010 | 41.35 |
| 03:20 ET | 20571 | 41.37 |
| 03:21 ET | 2028 | 41.355 |
| 03:23 ET | 2955 | 41.35 |
| 03:25 ET | 5256 | 41.27 |
| 03:27 ET | 3493 | 41.18 |
| 03:30 ET | 2654 | 41.14 |
| 03:32 ET | 827 | 41.1 |
| 03:34 ET | 3557 | 41.1 |
| 03:36 ET | 2552 | 41.06 |
| 03:38 ET | 5216 | 41 |
| 03:39 ET | 1824 | 40.94 |
| 03:41 ET | 3341 | 40.91 |
| 03:43 ET | 3050 | 40.92 |
| 03:45 ET | 4897 | 40.97 |
| 03:48 ET | 2833 | 41.08 |
| 03:50 ET | 9858 | 41.06 |
| 03:52 ET | 6748 | 41.07 |
| 03:54 ET | 9611 | 41.1 |
| 03:56 ET | 20608 | 41.01 |
| 03:57 ET | 20701 | 41.12 |
| 03:59 ET | 197214 | 41.13 |
Jun 3, 2024
DJ Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham, from 5:39AM ET on Monday Jun 03, 2024 by Dow Jones
5:39AM ET on Monday Jun 03, 2024 by Dow Jones
May 31, 2024
May 28, 2024
Ionis to hold donidalorsen Phase 3 data webcast, from 7:00AM ET on Tuesday May 28, 2024 by Dow Jones
7:00AM ET on Tuesday May 28, 2024 by Dow Jones
May 23, 2024
May 16, 2024
DJ Ionis to Fly Solo on Angelman Syndrome Drug -- Market Talk, from 11:52AM ET on Thursday May 16, 2024 by Dow Jones
11:52AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 5.8B | -15.4x | --- |
Halozyme Therapeutics Inc | 6.4B | 20.5x | --- |
Apellis Pharmaceuticals Inc | 5.2B | -12.3x | --- |
CRISPR Therapeutics AG | 5.3B | -24.2x | --- |
Guardant Health Inc | 3.7B | -8.0x | --- |
Azenta Inc | 3.0B | -20.0x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Executive Vice President, Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.8B |
|---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.36 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -15.4x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
